Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia

Blood

Volumn 103, Issue 7, 2004, Pages 2799-2801

  Rogers, Anna ^b   Joe, Youngson ^b   Manshouri, Taghi ^b   Dey, Amanda ^b   Jilani, Iman ^b   Giles, Francis ^b   Estey, Elihu ^b   Freireich, Emil ^b   Keating, Michael ^b   Kantarjian, Hagop ^b   Albitar, Maher ^a  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CELL; CANCER PATIENT; CHROMOSOME 17; CHROMOSOME 20; CHROMOSOME 5Q; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CLONING; CONTROLLED STUDY; CYTOGENETICS; DNA DETERMINATION; FEMALE; GENETIC DISORDER; GENOME; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; PLASMA; PRIORITY JOURNAL; X CHROMOSOME INACTIVATION;

EID: 12144290629     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-06-1840     Document Type: Article

References (18)

1. Albitar M, Manshouri T, Shen Y, et al. Myelodysplastic syndrome is not merely "preleukemia." Blood. 2002;100:791-798.
2. Chen X, Bonnefoi H, Diebold-Berger S, et al. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res. 1999;5:2297-2303.
3. Nakayama T, Taback B, Nguyen DH, et al. Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients. Ann N Y Acad Sci. 2000;906:87-98.
4. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med. 1996;2:1035-1037.
5. Sanchez-Cespedes M, Monzo M, Rosell R, et al. Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. Ann Oncol. 1998;9:113-116.
6. Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C, Stroun M. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol. 1994;86:774-779.
7. Frickhofen N, Muller E, Sandherr M, et al. Rearranged Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia. Blood. 1997;90:4953-4960.
8. Dasi F, Lledo S, Garcia-Granero E, et al. Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients. Lab Invest. 2001;81:767-769.
9. Jilani I, Estey E, Manshouri T, et al. Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA. Leukemia. 2003;17:114-119.
10. Feng BZ, Lei LJ, Han JZ. Cytogenetic studies on 334-myelodysplastic syndrome (MDS), aplastic anemia (AA) and other hematological diseases. Chung Hua Nei Ko Tsa Chih. 1994;33:754.
11. Ghaddar HM SS, Pierce S, Estey EH. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases. Leukemia. 1994;8:1649-1653.
12. Geddes AA, Bowen DT, Jacobs A. Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome. Br J Haematol. 1990;76:194-202.
13. Swansbury GJ. The proportion of clonal divisions varies in different hematologic malignancies. The United Kingdom Cancer Cytogenetics Groups (UKCCG). Cancer Genet Cytogenet. 1998;104:139-145.
14. Asimakopoulos FA, White NJ, Nacheva E, Green AR. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood. 1994;84:3086-3094.
15. Fairman J, Wang RY, Liang H, etal. Translocations and deletions of 5q13. 1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus. Blood. 1996;88:2259-2266.
16. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of Hpall and Hhal sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992;51:1229-1239.
17. Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. Proc Natl Acad Sci U S A. 1991;88:6848-6852.
18. Albitar M, Wu WC, Feltz E, et al. Simplified reverse dot blot analyses for detecting Ras oncogene mutations. Molecular Diagnosis. 1977;2:169-176.